Dr. Julio Jiménez

AIS Telesurgeon

What superpower would like to have as a surgeon? The superpower would be ubiquity; state or capacity of being everywhere. Every surgeon would like to have the best specialist advising them during surgery at any time.   AIS TeleSurgeon is a telementoring and remote surgical training system based on surgery learning that combines hardware and software. The full-fledged system allows plugins and plays images, videos, and any data from laparoscopic devices or an audio-visual signal in the operating theatre to allow remote surgeons to give visual indications to OR screens. Moreover, the system allows audio connection between the surgeon in the operating room (OR) with anyone outside the OR (from home, from an office, or another place in the hospital), that could be, for instance, another specialized surgeon or a sales representative who sold any medical instrumentation. The main goal of AIS Telesurgeon is to connect remotely surgeons around the world, to open a new world of collaborative surgeries and remote training.  Dr. Julio Jiménez will share with us his experience as the first surgeon in Chile to perform collaborative surgery in real-time using 5G.

Immunotherapy in Gastric Cancer

Gastric cancer is the 5th most frequent cancer worldwide, with more than a million new cases per year. This cancer also has a high mortality rate: 1 out of 12 oncological deaths is attributable to gastric cancer, resulting in a 5-year survival that varies from 10 to 30 percent depending on the country. Mostly this high mortality is attributable to late-stage diagnosis and poor outcomes in advanced cases. The traditional treatment scheme initiates right after diagnosis and staging, where tumours are classified as operable in the best.case scenario or as inoperable or metastatic. This is a critical step, as in gastric cancer patients surgical intervention gives the best outcomes with a 5-year survival rate for pre-metastatic diagnosis of 67%. Inoperable or metastatic patients are often treated with several lines of chemotherapy and only recently has immunotherapy been approved  for metastatic gastric cancer.  Immunotherapy has definitely revolutionized gastric cancer treatment, significantly improving patient survival. To understand how this therapy works we need to take a look at the cancer immune response.

Learning Curve and Training in Robotic Bariatric Surgery

While the use of robotic surgical technology has experienced exponential growth in many parts of the world and across numerous specialties, including bariatric surgery, standardized training and credentialing of robotic surgeons unfortunately remains in a nascent state. The need for a standardized robotic training curriculum is much needed and long overdue. The lack of a standardized training curriculum lends itself to serious disparity in the quality of robotic training depending on trainee location and specialty.

From Fellowship into Practice

Dr. Venkatesh Munikrishnan, Dr. Gabriela Moeslein, Dr. Eduardo Villegas, Dr. Julio Mayol, Dr. Silvia Valverde, Dr. Mark Soliman, Dr. Julio Jiménez present "Dr. Julio Jiménez".

With Johnson & Johnson MedTech

Revisional Surgery for Sleeve Gastrectomy: Why, What, How?

Laparoscopic sleeve gastrectomy has become increasingly popular as a primary bariatric procedure and, according to recent data, is the most common bariatric surgery worldwide. However, this primary surgery may fail, either due to poor weight loss results or due to specific complications of the procedure. In this conference we will briefly review revision surgery for sleeve gastrectomy and answer 3 questions: Why is this surgery performed? (Revision indications) What surgery is performed? (Surgical alternatives) How is surgery performed? (Surgical approach)

State of the Art of Bariatric Surgery in Chile

In this lecture we will briefly review bariatric surgery in Chile. Obesity and Diabetes Mellitus are a public health problem in Chile. Almost 75% of the population in Chile is overweight or obese. Chile is the OECD country with the highest obesity rate, the first in Latin America in childhood obesity and 14,000 people die each year from obesity-related diseases. When comparing the results with the previous national statistics, obesity grew from 22.9 to 31.2% in the last 6 years, while overweight remained at 40%. Regarding T2DM, the proportion of people older than 15 with DM increased from 4.2% in 2003 to 12.3% in 2017.Bariatric surgery is the most effective treatment alternative for obesity and current clinical evidence indicates that surgical treatment is superior to medical management in a vast majority of type-2 diabetic patients. According to data from the Chilean Society of Bariatric Surgery, approximately 8,000 bariatric surgeries are performed annually in Chile, where 64.6% correspond to sleeve gastrectomy and 33.2% to gastric bypass. 6.6% correspond to revision surgery. Recently the Chilean Societies of Endocrinology and Diabetes and of Bariatric and Metabolic Surgery decided to generate a consensus regarding the importance of other factors related to DM2 that would allow a better selection of candidates for surgery.